ESTRO 2020 Abstract Book

Symposium Current status of radiotherapy for non-malignant disease outside the brain............................................. (Abs. 762-765) Joint Symposium ESTRO-ESR: Online MR-guided radiotherapy - Where are we right now?..................................................... (Abs. 766-769) Debate This house believes that radiomics will improve predictive models in RT................................................... (Abs. 770-773) Symposium Tumour tracking – is it worth the effort?......................................................................................................... (Abs. 774-777) Particle Therapy - possibilities and limitations................................................................................................ (Abs. 778-780) POSTERS Clinical track: Head and Neck............................................................................................................................ (Abs. 786-854) Clinical track: CNS............................................................................................................................................... (Abs. 855-909) Clinical track: Haematology............................................................................................................................... (Abs. 910-924) Clinical track: Breast........................................................................................................................................... (Abs. 925-986) Clinical track: Lung. .......................................................................................................................................... (Abs. 988-1033) Clinical track: Upper GI (oesophagus, stomach, pancreas, liver)............................................................... (Abs. 1034-1078) Clinical track: Lower GI (colon, rectum, anus).............................................................................................. (Abs. 1079-1115) Clinical track: Gynaecological (endometrium, cervix, vagina, vulva)......................................................... (Abs. 1116-1148) Clinical track: Prostate................................................................................................................................... (Abs. 1149-1204) Clinical track: Urology-non-prostate............................................................................................................. (Abs. 1205-1221) Clinical track: Skin cancer / malignant melanoma...................................................................................... (Abs. 1222-1228) Clinical track: Sarcoma................................................................................................................................... (Abs. 1229-1236) Clinical track: Paediatric tumours................................................................................................................. (Abs. 1237-1244) Clinical track: Palliation.................................................................................................................................. (Abs. 1245-1262) Clinical track: Elderly...................................................................................................................................... (Abs. 1263-1272) Clinical track: Health services research / health economics...................................................................... (Abs. 1273-1284) Clinical track: Communication. ..................................................................................................................... (Abs. 1285-1288) Clinical track: Other........................................................................................................................................ (Abs. 1289-1305) Physics track: Basic dosimetry and phantom and detector development............................................... (Abs. 1306-1335) Physics track: Dose measurement and dose calculation........................................................................... (Abs. 1336-1422) Physics track: Radiation protection, secondary tumour induction and low dose.................................... (Abs. 1423-1433) Physics track: Treatment plan optimisation: algorithms............................................................................ (Abs. 1434-1463) Physics track: Treatment planning: applications......................................................................................... (Abs. 1464-1522) Physics track: Radiobiological and predictive modelling, and radiomics.................................................. (Abs. 1523-1586) Physics track: Intra-fraction motion management...................................................................................... (Abs. 1587-1621) Physics track: Adaptive radiotherapy and inter-fraction motion management....................................... (Abs. 1622-1673) Physics track: Quantitative functional and biological imaging. ................................................................. (Abs. 1674-1696) Physics track :Imaging acquisition and processing..................................................................................... (Abs. 1697-1756) Physics track: Implementation of new technology, techniques, clinical protocols or trials (including QA & audit)...................................................................................................................... (Abs. 1757-1801) Radiobiology track: Radiobiology of normal tissues................................................................................... (Abs. 1802-1807) Radiobiology track: Radiobiology of stem cells (canser and normal tissue). .....................................................(Abs. 1808) Radiobiology track: Radiobiology of particles and heavy ions.............................................................................(Abs. 1809) Radiobiology track: Tumour microenvironment...................................................................................................(Abs. 1810) Radiobiology track: Immuno-radiobiology................................................................................................... (Abs. 1811-1821) Radiobiology track: Radiation and tumour metabolism.......................................................................................(Abs. 1822) Radiobiology track: DNA damage response................................................................................................ (Abs. 1823-1826) Radiobiology track: Biological therapies (e.g. viruses, vaccines).........................................................................(Abs. 1827) RTT track: Patient preparation, positioning and immobilisation............................................................... (Abs. 1828-1844) RTT track: Imaging acquisition and registration, OAR and target definition............................................ (Abs. 1845-1851) RTT track: Treatment planning and dose calculation / QC and QA........................................................... (Abs. 1852-1882) RTT track: Image guided radiotherapy and verification protocols............................................................ (Abs. 1883-1910) RTT track: Motion management and adaptive strategies. ......................................................................... (Abs. 1911-1923) RTT track: Patient care, side effects and communication. ......................................................................... (Abs. 1924-1932) RTT track: Education and training/role development................................................................................. (Abs. 1933-1942) RTT track: Risk management/quality management.................................................................................... (Abs. 1943-1947)